Gladius Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,098	Closed	-$35.7K	–	272
2023 Q4	$35.7K	Buy	+1,098	New	+$35.7K	0.01%	162
2022 Q3	–	Sell	-1,288	Closed	-$31K	–	336
2022 Q2	$31K	Buy	+1,288	New	+$31K	﹤0.01%	233